B. Riley Financial, Inc. Journey Medical Corp Transaction History

B. Riley Financial, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.66 - $2.97 $537,670 - $961,977	-323,898 Reduced 42.99%	429,595 $1.18 Million
Q2 2023 Aug 08, 2023	SELL	$1.03 - $2.26 $21,942 - $48,144	-21,303 Reduced 2.75%	753,493 $1.2 Million
Q1 2023 May 09, 2023	SELL	$1.28 - $2.54 $115,070 - $228,343	-89,899 Reduced 10.4%	774,796 $1.22 Million
Q4 2021 Feb 10, 2022	BUY	$5.17 - $9.9 $4.47 Million - $8.56 Million	864,695 New	864,695 $4.65 Million

2.93M

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $44.1M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.